DarioHealth Corp expected to post a loss of 52 cents a share - Earnings Preview

DarioHealth

08/08/2023 19:34

* DarioHealth Corp  DRIO.OQ   DRIO.O  is expected to show a
rise
in quarterly revenue when it reports  results on August 10. 
    * The New York City-based  company is expected to report  a
4.5% increase in revenue to $6.459 million from $6.18 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for DarioHealth Corp is
for a
loss of 52 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $8​, above​ its last closing price of $3.37. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.49       -0.50      -0.45     Beat    9.6
 Dec. 31 2023  -0.56       -0.65      -0.51     Beat    21.8
 Sep. 30 2022  -0.71       -0.76      -0.64     Beat    16.1​
 Jun. 30 2022  -0.71       -0.71      -0.74     Missed  -3.9
 ​​Mar.        -0.96       -0.96      -0.74     Beat    22.7
 31 2022                                                
 Dec. 31 2021  -1.09       -1.06      -1.09     Missed  -3.2​
 Sep. 30 2021  -0.91       -0.94      -1.18     Missed  -26.1
 Jun. 30 2021  -0.87       -0.85      -0.99     Missed  -15.8
 This summary was machine generated August 8 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated